Petauri Unites Mtech Access and Delta Hat Under One Team–Petauri Evidence
Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions. NASHVILLE, Tenn., April 16, 2025 /PRNewswire/ -- Petauri,...
Healthcare
Kyndryl Launches New AI Private Cloud Services to Speed Customer Development and Deployment of Enterprise AI Solutions
Kyndryl Consult to facilitate customer design, build and implementation of AI workloads Kyndryl AI Private Cloud services support collaborations with...
Reliant Specialty Infusion Partners with Tennr to Scale and Accelerate Patient Access
NEW YORK, April 16, 2025 /PRNewswire/ -- Tennr, the intelligent automation platform for healthcare operations, has announced a strategic partnership...
WHO and WEF Are Pushing AI in Global Healthcare — What It Means for the Market
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 16, 2025 /PRNewswire/ -- Equity Insider News...
HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced...
Avalon Healthcare Solutions Secures Patent for Groundbreaking Lab Claims Review Technology
APEA platform recognized for transforming real-time policy enforcement and powering smarter diagnostics decisions TAMPA, Fla., April 16, 2025 /PRNewswire/ --...
Assembly Health™ Expands Its Revenue Cycle Management Leadership with New Executive Team Members
CHICAGO, April 16, 2025 /PRNewswire/ -- Assembly Health, a leading revenue cycle management provider to thousands of physician practices, post-acute...
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit
LAS VEGAS, April 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova...
Doheny Eye Institute Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
More than 25 Doheny Scientists and Clinician-Scientists to Present Posters, Papers and Mini symposia at Leading Eye Research ConferencePASADENA, Calif.,...
Biomerica Announces Reverse Stock Split
Shares Expected to Begin Trading on Split-Adjusted Basis on April 21, 2025IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica,...
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides...
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO...
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands...
MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30
MARIETTA, Ga., April 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...
Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough
Scientists reveal GPDT (Green Products Photodynamic Technology) Oxperial BioHealth has revealed a major breakthrough in cancer prevention OXFORD, United Kingdom,...
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2...
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by...
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the...
Healthera secures £2m strategic investment to accelerate digital pharmacy platform growth and North American expansion
An additional £2 million in new funding from private investors takes the company's Series A round to £5.6 million total...